India to Uzbekistan: Ifosfamide Export Trade Route
India has recorded 9 verified shipments of Ifosfamide exported to Uzbekistan, representing a combined trade value of $614.3K USD. This corridor is served by 3 active Indian exporters, with an average shipment value of $68.3K USD. The leading Indian exporter is VIVALIA REMEDIES PRIVATE LIMITED , which accounts for 97% of total export value with 5 shipments worth $593.8K USD. On the buying side, VEF SAU is the largest importer in Uzbekistan with $480.0K USD in purchases. The top 3 suppliers — VIVALIA REMEDIES PRIVATE LIMITED , VIVALIA REMEDIES PRIVATE LIMITED, APRAZER HEALTHCARE PRIVATE LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Uzbekistan Ifosfamide corridor is one of India's established pharmaceutical export routes, with 9 shipments documented worth a combined $614.3K USD. The route is dominated by VIVALIA REMEDIES PRIVATE LIMITED , which alone accounts for roughly 97% of all export value, reflecting the consolidated nature of India's ifosfamide manufacturing sector.
Across 3 active suppliers, the average shipment value stands at $68.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 75% of all shipments, consistent with ifosfamide's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 33.2%, placing it at rank #10 among India's top ifosfamide export destinations globally.
On the import side, key buyers of Indian ifosfamide in Uzbekistan include VEF SAU , LLC OZMEDIMPEKS , ALINFARM MEDICAL CO LIMITED and 3 others. VEF SAU is the single largest importer with 3 shipments valued at $480.0K USD.
Route Characteristics
- Average transit27 days
- Peak seasonQ4
- Primary modeSea freight
- Top portDELHI AIR CARGO ACC (INDEL4)
Market Position
- Global rank#10
- Annual growth+33.2%
- Demand growth+29.5%
- Regulatory ease78/100
Top 10 Indian Ifosfamide Exporters to Uzbekistan
Showing top 10 of 3 Indian suppliers exporting Ifosfamide to Uzbekistan, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | VIVALIA REMEDIES PRIVATE LIMITED Avg $118.8K per shipment | 5 | $593.8K | 96.7% |
| 2 | VIVALIA REMEDIES PRIVATE LIMITED Avg $7.4K per shipment | 2 | $14.9K | 2.4% |
| 3 | APRAZER HEALTHCARE PRIVATE LIMITED Avg $2.8K per shipment | 2 | $5.5K | 0.9% |
This table shows the top 10 of 3 Indian companies exporting ifosfamide to Uzbekistan, ranked by total trade value. The listed exporters are: VIVALIA REMEDIES PRIVATE LIMITED , VIVALIA REMEDIES PRIVATE LIMITED, APRAZER HEALTHCARE PRIVATE LIMITED. VIVALIA REMEDIES PRIVATE LIMITED is the dominant supplier with 5 shipments worth $593.8K USD, giving it a 97% market share.
Top 10 Ifosfamide Importers in Uzbekistan
Showing top 10 of 6 known buyers in Uzbekistan receiving Ifosfamide shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian ifosfamide in Uzbekistan include VEF SAU , LLC OZMEDIMPEKS , ALINFARM MEDICAL CO LIMITED, OOO GOLD GROWN PHARMA, TO THE ORDER OF, among 6 total buyers. The largest importer is VEF SAU , accounting for $480.0K USD across 3 shipments — representing 78% of all ifosfamide imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | VEF SAU | 3 | $480.0K | 78.1% |
| 2 | LLC OZMEDIMPEKS | 2 | $113.8K | 18.5% |
| 3 | ALINFARM MEDICAL CO LIMITED | 1 | $7.8K | 1.3% |
| 4 | OOO GOLD GROWN PHARMA | 1 | $7.1K | 1.2% |
| 5 | TO THE ORDER OF | 1 | $3.7K | 0.6% |
| 6 | SOF PHARM LLC | 1 | $1.8K | 0.3% |
Top 10 Ifosfamide Formulations Imported by Uzbekistan
Showing top 10 of 6 product formulations shipped on the India to Uzbekistan Ifosfamide route, ranked by trade value
Uzbekistan imports a wide range of ifosfamide formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — FOSFA + MESNA (Ifosfamide 1gm with Mesna — accounts for $480.0K USD across 3 shipments. A total of 6 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | FOSFA + MESNA (Ifosfamide 1gm with Mesna | 3 | $480.0K | 78.1% |
| 2 | FOSFA + MESNA (Ifosfamide 1gm with Mesn | 2 | $113.8K | 18.5% |
| 3 | FOSFA 1G IFOSFAMIDE FOR INJ. WITH MESNA 2 MLBATCH NO. 3GIP09 MANUFACTURING .DT. 08/2023 EXP.DT. 07/2025 BATCH NO. 3GMS14 MANUFACTURING .D | 1 | $7.8K | 1.3% |
| 4 | FOSFA C MESNA 1G ( IFOSFAMIDE FOR INJ.WITH MESNA 200MG/2ML) BATCH NO. 4GIP01, MFG.DT. 01/2024, EXP.DT. 12/2025 BATCH | 1 | $7.1K | 1.2% |
| 5 | IFOSMA 1000 IFOSFAMIDE 1 GM B/N-OL0901,MFG-01/25, EXP-12/26 | 1 | $3.7K | 0.6% |
| 6 | IFOSMA 1000 IFOSFAMIDE FOR INJECTION IPW | 1 | $1.8K | 0.3% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 75%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
DELHI AIR CARGO ACC (INDEL4) handles the highest volume with 6 shipments. Transit time averages 27 days by sea.
Market Dynamics
India's ifosfamide exports to Uzbekistan are driven primarily by a handful of large-scale manufacturers. VIVALIA REMEDIES PRIVATE LIMITED with 5 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Uzbekistan benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — VIVALIA REMEDIES PRIVATE LIMITED , VIVALIA REMEDIES PRIVATE LIMITED, APRAZER HEALTHCARE PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $68.3K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as fosfa + mesna (ifosfamide 1gm with mesn and fosfa 1g ifosfamide for inj. with mesna 2 mlbatch no. 3gip09 manufacturing .dt. 08/2023 exp.dt. 07/2025 batch no. 3gms14 manufacturing .d, suggesting that buyers in Uzbekistan tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, VEF SAU is the largest importer with 3 shipments worth $480.0K USD — representing 78% of all ifosfamide imports from India on this route. A total of 6 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $614.3K
- Avg. Shipment
- $68.3K
- Suppliers
- 3
- Buyers
- 6
- Transit (Sea)
- ~27 days
- Annual Growth
- +33.2%
Related Analysis
Other Ifosfamide Routes
Unlock the Full India to Uzbekistan Ifosfamide Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 9 shipments on this route.
Frequently Asked Questions — India to Uzbekistan Ifosfamide Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Ifosfamide to Uzbekistan?
The leading Indian exporters of Ifosfamide to Uzbekistan are VIVALIA REMEDIES PRIVATE LIMITED , VIVALIA REMEDIES PRIVATE LIMITED, APRAZER HEALTHCARE PRIVATE LIMITED. VIVALIA REMEDIES PRIVATE LIMITED holds the largest market share at approximately 97% of total trade value on this route.
Q What is the total value of Ifosfamide exports from India to Uzbekistan?
India exports Ifosfamide to Uzbekistan worth approximately $614.3K USD across 9 recorded shipments. The average value per shipment is $68.3K USD.
Q Which ports does India use to ship Ifosfamide to Uzbekistan?
The most active port of origin is DELHI AIR CARGO ACC (INDEL4) with 6 shipments. Indian exporters primarily use sea freight for this route, with 75% of shipments going by sea and 23% by air.
Q How long does shipping take from India to Uzbekistan for Ifosfamide?
The average transit time for Ifosfamide shipments from India to Uzbekistan is approximately 27 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Uzbekistan Ifosfamide trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 33.2% with demand growth tracking at 29.5%. The route is ranked #10 among India's top Ifosfamide export destinations globally.
Q How many suppliers are active on the India to Uzbekistan Ifosfamide route?
There are currently 3 active Indian suppliers exporting Ifosfamide to Uzbekistan. The market is moderately concentrated with VIVALIA REMEDIES PRIVATE LIMITED accounting for 97% of total shipment value.
Q Who are the main importers of Ifosfamide from India in Uzbekistan?
The leading importers of Indian Ifosfamide in Uzbekistan include VEF SAU , LLC OZMEDIMPEKS , ALINFARM MEDICAL CO LIMITED, OOO GOLD GROWN PHARMA, TO THE ORDER OF. VEF SAU is the largest buyer with 3 shipments worth $480.0K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Uzbekistan export trade corridor identified from Indian Customs (DGFT) records for Ifosfamide.
- 2.Supplier/Buyer Matching: 3 Indian exporters and 6 importers in Uzbekistan matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 9 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
9 Verified Shipments
3 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists